Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib for Desensitization in Kidney Transplantation
NCT03213158Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2017
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in end stage renal disease (ESRD), sponsored by University of Wisconsin–Madison. Started Sep 2017; status: completed.
02
Drugs
ixazomib
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03213158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03213158.